Augmented Therapeutic Potential of EC-Synthetic Retinoids in Caco-2 Cancer Cells Using an In Vitro Approach

Colorectal cancer therapies have produced promising clinical responses, but tumor cells rapidly develop resistance to these drugs. It has been previously shown that EC19 and EC23, two EC-synthetic retinoids, have single-agent preclinical anticancer activity in colorectal carcinoma. Here, isobologram...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelaal, Mohamed R., Ibrahim, Esraa, Elnagar, Mohamed R., Soror, Sameh H., Haffez, Hesham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409216/
https://www.ncbi.nlm.nih.gov/pubmed/36012706
http://dx.doi.org/10.3390/ijms23169442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409216/
https://www.ncbi.nlm.nih.gov/pubmed/36012706
http://dx.doi.org/10.3390/ijms23169442

Ejemplares similares